A Multicenter, Real-world Study of Adebrelimab in the Treatment of Extensive Stage Small Cell Lung Cancer
Clinical trial NCT06267170 · UNKNOWN
Trial details
- NCT number
- NCT06267170
- Sponsor
- Henan Cancer Hospital
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2024-02-25
- Primary completion
- 2025-02-25
- Enrollment
- 288
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.